• Home
  • Search Results
  • 5-HT obesity medication efficacy via POMC activation is maintained during aging.

5-HT obesity medication efficacy via POMC activation is maintained during aging.

Endocrinology (2014-07-23)
Luke K Burke, Barbora Doslikova, Giuseppe D'Agostino, Alastair S Garfield, Gala Farooq, Denis Burdakov, Malcolm J Low, Marcelo Rubinstein, Mark L Evans, Brian Billups, Lora K Heisler

The phenomenon commonly described as the middle-age spread is the result of elevated adiposity accumulation throughout adulthood until late middle-age. It is a clinical imperative to gain a greater understanding of the underpinnings of age-dependent obesity and, in turn, how these mechanisms may impact the efficacy of obesity treatments. In particular, both obesity and aging are associated with rewiring of a principal brain pathway modulating energy homeostasis, promoting reduced activity of satiety pro-opiomelanocortin (POMC) neurons within the arcuate nucleus of the hypothalamus (ARC). Using a selective ARC-deficient POMC mouse line, here we report that former obesity medications augmenting endogenous 5-hydroxytryptamine (5-HT) activity d-fenfluramine and sibutramine require ARC POMC neurons to elicit therapeutic appetite-suppressive effects. We next investigated whether age-related diminished ARC POMC activity therefore impacts the potency of 5-HT obesity pharmacotherapies, lorcaserin, d-fenfluramine, and sibutramine and report that all compounds reduced food intake to a comparable extent in both chow-fed young lean (3-5 months old) and middle-aged obese (12-14 months old) male and female mice. We provide a mechanism through which 5-HT anorectic potency is maintained with age, via preserved 5-HT-POMC appetitive anatomical machinery. Specifically, the abundance and signaling of the primary 5-HT receptor influencing appetite via POMC activation, the 5-HT2CR, is not perturbed with age. These data reveal that although 5-HT obesity medications require ARC POMC neurons to achieve appetitive effects, the anorectic efficacy is maintained with aging, findings of clinical significance to the global aging obese population.

Product Number
Product Description

Formaldehyde solution, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
Formaldehyde solution, for molecular biology, BioReagent, ≥36.0% in H2O (T)
Formaldehyde solution, meets analytical specification of USP, ≥34.5 wt. %
Formaldehyde solution, tested according to Ph. Eur.
Formaldehyde solution, for molecular biology, 36.5-38% in H2O
Formaldehyde solution, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Formaldehyde-12C solution, 20% in H2O, 99.9 atom % 12C
Formaldehyde solution, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Serotonin hydrochloride, powder